chr19-38403667-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_174905.4(FAM98C):c.322G>A(p.Glu108Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0324 in 1,415,012 control chromosomes in the GnomAD database, including 807 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.034 ( 113 hom., cov: 32)
Exomes 𝑓: 0.032 ( 694 hom. )
Consequence
FAM98C
NM_174905.4 missense
NM_174905.4 missense
Scores
1
17
Clinical Significance
Conservation
PhyloP100: -0.00400
Genes affected
FAM98C (HGNC:27119): (family with sequence similarity 98 member C) Predicted to be part of tRNA-splicing ligase complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0019147396).
BP6
Variant 19-38403667-G-A is Benign according to our data. Variant chr19-38403667-G-A is described in ClinVar as [Benign]. Clinvar id is 3057083.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0343 (5228/152294) while in subpopulation AFR AF= 0.051 (2121/41574). AF 95% confidence interval is 0.0492. There are 113 homozygotes in gnomad4. There are 2533 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 113 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM98C | NM_174905.4 | c.322G>A | p.Glu108Lys | missense_variant | 3/8 | ENST00000252530.10 | NP_777565.3 | |
FAM98C | NM_001351675.1 | c.322G>A | p.Glu108Lys | missense_variant | 3/6 | NP_001338604.1 | ||
FAM98C | XM_017026354.2 | c.322G>A | p.Glu108Lys | missense_variant | 3/6 | XP_016881843.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM98C | ENST00000252530.10 | c.322G>A | p.Glu108Lys | missense_variant | 3/8 | 1 | NM_174905.4 | ENSP00000252530.4 |
Frequencies
GnomAD3 genomes AF: 0.0343 AC: 5216AN: 152182Hom.: 113 Cov.: 32
GnomAD3 genomes
AF:
AC:
5216
AN:
152182
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0259 AC: 1126AN: 43402Hom.: 15 AF XY: 0.0271 AC XY: 691AN XY: 25456
GnomAD3 exomes
AF:
AC:
1126
AN:
43402
Hom.:
AF XY:
AC XY:
691
AN XY:
25456
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0322 AC: 40660AN: 1262718Hom.: 694 Cov.: 32 AF XY: 0.0325 AC XY: 20030AN XY: 615852
GnomAD4 exome
AF:
AC:
40660
AN:
1262718
Hom.:
Cov.:
32
AF XY:
AC XY:
20030
AN XY:
615852
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0343 AC: 5228AN: 152294Hom.: 113 Cov.: 32 AF XY: 0.0340 AC XY: 2533AN XY: 74458
GnomAD4 genome
AF:
AC:
5228
AN:
152294
Hom.:
Cov.:
32
AF XY:
AC XY:
2533
AN XY:
74458
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
88
ESP6500EA
AF:
AC:
135
ExAC
AF:
AC:
2077
Asia WGS
AF:
AC:
84
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
FAM98C-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 28, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N;N
PrimateAI
Pathogenic
D
PROVEAN
Benign
.;N;N
REVEL
Benign
Sift
Benign
.;T;T
Sift4G
Benign
T;T;T
Polyphen
0.0060, 0.021
.;B;B
Vest4
MPC
1.3
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at